Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/12/17 | 8-K | Current report filing |
|
4 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/25/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/19/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
8 | |
| 05/19/17 | 8-K/A | Current report filing |
|
4 | |
| 05/19/17 | 8-K/A | Current report filing |
|
4 | |
| 05/18/17 | 8-K | Current report filing |
|
7 | |
| 05/18/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/15/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
42 |
